Home    Back

Rivaroxaban 20 mg    (DrugBank: Rivaroxaban)

5 diseases
IDDisease name (Link within this page)Number of trials
46Malignant rheumatoid arthritis0
49Systemic lupus erythematosus0
75Cushing disease0
91Budd-Chiari syndrome1
210Single Ventricle0

46. Malignant rheumatoid arthritis    [ 4,183 clinical trials,   2,538 drugs,   (DrugBank: 401 drugs),   183 drug target genes,   219 drug target pathways]
Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 4,183 trial found

49. Systemic lupus erythematosus    [ 827 clinical trials,   638 drugs,   (DrugBank: 168 drugs),   108 drug target genes,   191 drug target pathways]
Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 827 trial found

75. Cushing disease    [ 191 clinical trials,   172 drugs,   (DrugBank: 48 drugs),   61 drug target genes,   121 drug target pathways]
Searched query = "Cushing disease", "Cushing"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 191 trial found

91. Budd-Chiari syndrome    [ 3 clinical trials,   4 drugs,   (DrugBank: 3 drugs),   2 drug target genes,   8 drug target pathways]
Searched query = "Budd-Chiari syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 3 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2014-005162-29-NL
(EUCTR)		09/04/202013/06/2019Treatment of thrombosis in the abdominal veinsTreatment of portal, mesenteric, and splenic vein thrombosis with rivaroxaban. A pilot, prospective cohort study - RIVASVT100 Splanchnic vein thrombosis (SVT) is an unusual site manifestation of venous thromboembolism (VTE). It includes the Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT), mesenteric vein thrombosis (MVT) and splenic vein thrombosis (spVT). PVT is the most frequent manifestation of SVT, followed by MVT. ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]Trade Name: rivaroxaban 20 mg
Product Name: rivaroxaban		University of InsubriaNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		100Phase 4France;Canada;Germany;Netherlands;Italy

210. Single Ventricle    [ 47 clinical trials,   54 drugs,   (DrugBank: 23 drugs),   32 drug target genes,   66 drug target pathways]
Searched query = "Single Ventricle", "SV", "Single ventricle heart defect", "Univentricular heart", "UVH", "Single ventricular circulation syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 47 trial found